Michael Emami

Research Project:

Michael is interested in developing genetic therapeutic strategies for Duchenne muscular dystrophy (DMD).

Publications:

Polyrotaxane Nanocarriers Can Deliver CRISPR/Cas9 Plasmid to Dystrophic Muscle Cells to Successfully Edit the DMD Gene – Emami MR, Young CS, Ji Y, Liu X, Mokhonova, E., Pyle, A. D., Meng, H. and Spencer, M. J. (2019), Polyrotaxane Nanocarriers Can Deliver CRISPR/Cas9 Plasmid to Dystrophic Muscle Cells to Successfully Edit the DMD Gene. Adv. Therap. 2019. doi: 1002/adtp.201900061